138 related articles for article (PubMed ID: 37975244)
1. Uptake of novel therapies into first-line treatment for acute myeloid leukemia patients: EU4 + UK perspective.
Ruiz M; Jindal K; Casey V; Soares LM; Manuguid F; Moehler T
Future Oncol; 2024 Mar; 20(9):533-546. PubMed ID: 37975244
[TBL] [Abstract][Full Text] [Related]
2. Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western Europe.
Kabra M; Margotto L; Manuguid F
Future Oncol; 2021 Jul; 17(21):2769-2784. PubMed ID: 33881356
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns in patients with acute myeloid leukemia in the United States: a cross-sectional, real-world survey.
Medeiros BC; Pandya BJ; Hadfield A; Pike J; Wilson S; Mueller C; Bui CN; Flanders SC; Rider A; Horvath Walsh LE
Curr Med Res Opin; 2019 May; 35(5):927-935. PubMed ID: 30712406
[TBL] [Abstract][Full Text] [Related]
4. Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review.
Heuser M; Fernandez C; Hauch O; Klibanov OM; Chaudhary T; Rives V
Future Oncol; 2023 Apr; 19(11):789-810. PubMed ID: 37170899
[TBL] [Abstract][Full Text] [Related]
5. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach.
Kantarjian HM; Kadia TM; DiNardo CD; Welch MA; Ravandi F
Cancer; 2021 Apr; 127(8):1186-1207. PubMed ID: 33734442
[TBL] [Abstract][Full Text] [Related]
7. Health state utilities associated with treatment options for acute myeloid leukemia (AML).
Matza LS; Deger KA; Howell TA; Koetter K; Yeager AM; Hogge D; Fisher V; Louie AC; Chung KC
J Med Econ; 2019 Jun; 22(6):567-576. PubMed ID: 30775943
[No Abstract] [Full Text] [Related]
8. Incorporation of Novel therapies for the treatment of acute myeloid leukemia: a perspective.
Waksal JA; Tallman MS
Leuk Lymphoma; 2021 Apr; 62(4):779-790. PubMed ID: 33541192
[TBL] [Abstract][Full Text] [Related]
9. Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes.
Dharmani C; Wang E; Tu N; Fofah O; Cueto J; Salas M; Kamel YM
Future Oncol; 2023 Aug; 19(24):1677-1693. PubMed ID: 37345543
[TBL] [Abstract][Full Text] [Related]
10. Current and emerging therapies for acute myeloid leukemia.
Robak T; Wierzbowska A
Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
[TBL] [Abstract][Full Text] [Related]
11. Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international study.
Ito T; Sanford D; Tomuleasa C; Hsiao HH; Olivera LJE; Enjeti AK; Conca AG; Del Castillo TB; Girshova L; Martelli MP; Guvenc B; Bui CN; Delgado A; Duan Y; Guijarro BG; Llamas C; Lee JH
Eur J Haematol; 2022 Jul; 109(1):58-68. PubMed ID: 35298049
[TBL] [Abstract][Full Text] [Related]
12. Patient characteristics, treatment patterns, and mortality in elderly patients newly diagnosed with acute myeloid leukemia meeting ineligibility criteria for high intensity chemotherapy.
Li S; Ji Y; Peng Y; Kota V; Kim C
Leuk Lymphoma; 2022 Jan; 63(1):131-141. PubMed ID: 34643153
[TBL] [Abstract][Full Text] [Related]
13. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
[TBL] [Abstract][Full Text] [Related]
14. Real-World Outcomes of Patients with Acute Myeloid Leukemia in Taiwan: A Nationwide Population-Based Study, 2011-2015.
Wang CY; Huang HH; Chen HM; Hsiao FY; Ko BS
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e649-e657. PubMed ID: 33931380
[TBL] [Abstract][Full Text] [Related]
15. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with Down syndrome and acute leukemia: A retrospective observational study.
Schmidt MP; Colita A; Ivanov AV; Coriu D; Miron IC
Medicine (Baltimore); 2021 Oct; 100(40):e27459. PubMed ID: 34622870
[TBL] [Abstract][Full Text] [Related]
17. Congenital acute myeloid leukemia: challenges and lessons. A 15-year experience from the UK.
Green K; Tandon S; Ahmed M; Toscano W; O'Connor D; Ancliff P; Vora A; Bartram J; Samarasinghe S; Ghorashian S; Pavasovic V; Rao A
Leuk Lymphoma; 2021 Mar; 62(3):688-695. PubMed ID: 33225799
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database.
Dharmani C; Wang E; Tu N; Salas M; Kamel YM
Future Oncol; 2023 Jan; 19(2):159-171. PubMed ID: 36912693
[TBL] [Abstract][Full Text] [Related]
19. New agents for the treatment of acute myeloid leukemia.
Tallman MS
Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128
[TBL] [Abstract][Full Text] [Related]
20. Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database.
Pandya BJ; Chen CC; Medeiros BC; McGuiness CB; Wilson SD; Walsh EH; Wade RL
J Manag Care Spec Pharm; 2020 Jul; 26(7):849-859. PubMed ID: 32281456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
